Pathophysiology · MU Sofia

39. Alzheimer's disease - etiology, pathogenesis, clinical manifestations.

Inside: 1 section · 15 flashcards · 2 min

Topic 39 of 168 in the MU Sofia syllabus for Pathophysiology (Medicine, Year 3). The free AceMed note covers it in 1 section, about 312 words (2 min of reading), with 15 flashcards.

In this note

  1. Alzheimer's disease – etiology, pathogenesis, and clinical manifestations.

Alzheimer's disease – etiology, pathogenesis, and clinical manifestations.

Alzheimer’s disease is a progressive neurodegenerative disorder and the most common cause of dementia, characterized by progressive memory loss, cognitive

dysfunction, and behavioral changes.

Etiology (Causes)

  1. 1 Genetic factors
  • Familial (early-onset) AD: ~1–5% of cases, onset before 65 years.
  • Mutations in:
  • APP (amyloid precursor protein) gene (chromosome 21).
  • Presenilin 1 (PSEN1)gene (chromosome 14).
  • Presenilin 2 (PSEN2) gene (chromosome 1).
  • Sporadic (late-onset) AD: most common.
  • Strongly associated with APOE ε4 allele (Apolipoprotein E gene).
  1. 2 Environmental factors
  • Age (most significant risk factor).
  • Head trauma.
  • Low educational attainment (possibly related to lower cognitive reserve).

Pathogenesis

  1. 1 Accumulation of β-amyloid plaques
  • Abnormal cleavage of APP → generation of Aβ peptide (especially Aβ42).
  • Aβ peptides aggregate extracellularly → form senile (neuritic) plaques.
  • Plaques disrupt neuronal function and promote inflammation.
  1. 2 Neurofibrillary tangles (NFTs)
  • Hyperphosphorylated tau protein accumulates intracellularly → forms paired helical filaments → neurofibrillary tangles.
  • Leads to microtubule destabilization and neuronal death.
  1. 3 Neuroinflammation and oxidative stress
  • Activation of microglia and astrocytes → release of cytokines and reactive oxygen species.
  • Further neuronal injury and synaptic dysfunction.
  1. 4 Neurotransmitter deficits
  • Significant loss of cholinergic neurons in basal forebrain (especially nucleus basalis of Meynert) → decreased acetylcholine levels → contributes to cognitive deficits.

Affected brain regions

  • Early: hippocampus and entorhinal cortex (memory-related areas).
  • Later: widespread cortical atrophy, including parietal and frontal lobes.

Clinical Manifestations

  1. 1 Early stage
  • Subtle short-term memory loss (difficulty recalling recent events).
  • Word-finding difficulty (anomia).
  • Mild disorientation (losing objects, getting lost in familiar places).
  1. 2 Progressive stage
  • Severe memory impairment (both short-term and eventually long-term).
  • Impaired judgment and problem-solving.
  • Difficulty with language (aphasia), visuospatial skills, and executive function.
  • Behavioral and personality changes:
  • Apathy.
  • Agitation, aggression.
  • Depression or anxiety.
  • Wandering behavior.
  1. 3 Late stage
  • Profound cognitive decline.
  • Inability to perform activities of daily living.
  • Incontinence.
  • Motor dysfunction (rigidity, spasticity).
  • Eventually bedridden; complications like infections lead to death.

Other features

  • Seizures in some patients.
  • Sleep disturbances.

Read the full note free

The whole note is free with an AceMed account, with its 15 flashcards. Premium adds flashcard recall, highlights and Ask AI.